Cochrane Review Protocol Outlines Comprehensive Evaluation of Drug Treatments for Anemia in Myelodysplastic Syndromes
Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).
Abstract
A new Cochrane Review protocol aims to systematically evaluate the benefits and harms of supportive and disease-modifying drugs for myelodysplastic syndromes (MDS)-related anemia.